Sergey Pigarev

Has grant

Chief Technical Officer

RDInnovation ApS

Denmark

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Sergey Pigarev is the Chief Technical Officer at RDInnovation ApS in Denmark. His research focuses on carcinogenesis, particularly the effects of urethane exposure and polyphenolic compositions on lung cancer development in progeny. He has also explored the antigenotoxic and antimutagenic properties of lignin derivatives and their potential applications in anticancer therapies.

Recent Grants

Grant: Close

ERMES EVALUATION OF RADIOMITIGATIVE EFFICACY AND SAFETY OF BP-C2

Open Date: 2020-05-01

Close Date: 2022-04-30

Grant: Close

ERMES EVALUATION OF RADIOMITIGATIVE EFFICACY AND SAFETY OF BP-C2

Open Date: 2020-05-01

Close Date: 2021-04-30

Articles (10)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (1)

Nikolay Solovyev

Lecturer

Atlantic Technological University

IRELAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sergey Pigarev

Research Interests

Contact this professor

About

Recent Grants

Articles (10)

Urethane-induced transgenerational carcinogenesis in the offsprings of BALB/c male mice exposed to total body gamma irradiation

Effect of polyphenolic composition BP-C2 on lung carcinogenesis induced with urethane in progeny of irradiated BALB/c male mice

Antigenotoxic and antimutagenic effects of lignin derivative BP-C2 against dioxidine and cyclophosphamide in vivo in murine cells

Antigenotoxic and antimutagenic effects of lignin derivative BP-C2 against dioxidine and cyclophosphamide in vivo in murine cells

Assessment of antitumor activity of BP-C1, a platinum-based anticancer agent with a lignin-derived polymeric ligand, in autochthonous induced and spontaneous carcinogenesis rodent models

Protein Binding of a Novel Platinum-Based Anticancer Agent BP-C1 Containing a Lignin-Derived Polymeric Ligand

A use of tritium-labeled peat fulvic acids and polyphenolic derivatives for designing pharmacokinetic experiments on mice

A Use of Tritium-Labeled Peat Fulvic Acids and Polyphenolic Derivatives for Designing Pharmacokinetic Experiments on Mice

Evaluation of the genotoxic and antigenotoxic potential of lignin-derivative BP-C2 in the comet assay in vivo

Evaluation of the genotoxic and antigenotoxic potential of lignin-derivative BP-C2 in the comet assay in vivo

Collaborators (1)

Nikolay Solovyev

Make your next move.